Source: International Congress 2017 – From microbiology to clinical work
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Um (Busan, Republic of Korea). Half Dose Urokinase Can Be Effective in Patients with Complicated Parapneumonic Effusion.. 4132

Member's Comments

No comment yet.

Related content which might interest you: Efficacy And Safety Of Thoracoscopic Cryobiopsy In Patients With Undiagnosed Exudative Pleural Effusion Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 Efficacy of Matrix Metalloproteinase-9 in Differentiating Tuberculous from Non-Tuberculous Pleural Effusion Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Non Invasive Ventilation in Acute Respiratory Failure in Patients of Post Tubercular Bronchiectasis: Effectiveness and Predictors of Failure. Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 EPIToME (Early Pleurodesis via IPC with Talc for Malignant Effusion): Evaluation of a new management algorithm Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: ERS Course 2015 Year: 2015 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Bedside  Ultrasound and Pigtail Catheters for Management of Pleural Effusion in Geriatric Population Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Predictors of Progression in Patients with Pulmonary Sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018